SCHEMBL19377360

SCHEMBL19377360

CC(NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNC3)cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.52
▸ HTR6 P50406 3/20 0.50
▸ DRD2 P14416 2/20 0.50
▸ DRD3 P35462 2/20 0.50
▸ IDH1 O75874 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ NAMPT P43490 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ KCNA5 P22460 1/20 0.45
▸ MTOR P42345 1/20 0.45
▸ ITGB3 P05106 2/20 0.45
▸ ITGA2B P08514 2/20 0.45
▸ LMNA P02545 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377040 0.85 IDH1 (0.52) HSD17B10HTR6DRD2DRD3IDH1
SCHEMBL19377077 0.85 IDH1 (0.52) HSD17B10HTR6DRD2DRD3IDH1
SCHEMBL19377273 0.85 IDH1 (0.54) HTR6DRD2DRD3IDH1HTT
SCHEMBL19377160 0.84 HTR6 (0.47) HTR6DRD2DRD3IDH1GFER
SCHEMBL19377220 0.83 HSD17B10 (0.49) HSD17B10IDH1GFERNAMPTCYP2C9
SCHEMBL19377218 0.83 HSD17B10 (0.49) HSD17B10IDH1GFERNAMPTCYP2C9
SCHEMBL19377663 0.83 HSD17B10 (0.49) HSD17B10IDH1GFERNAMPTCYP2C9
SCHEMBL19377311 0.82 HSD17B10 (0.55) HSD17B10MTORITGB3ITGA2BKMT2A
SCHEMBL19377375 0.82 ROCK2 (0.55) HSD17B10HTR6DRD2DRD3IDH1
SCHEMBL19377378 0.82 ROCK2 (0.55) HSD17B10HTR6DRD2DRD3IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR HSD17B10 2852/4885HTR6 231/4885DRD2 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback